Introduction
============

Skin aging is a progressive and degenerative process caused by a decrease in the physiological functions of skin tissue (dermis and epidermis). In addition, environmental factors, such as sun exposure and pollution, as well as concomitant diseases and lifestyle factors (nutrition, sedentary lifestyle, smoking, etc.) negatively affect skin tissue by increasing oxidation levels, thus leading to a chronic inflammatory state of the skin. This is often subclinical; however, these factors accelerate the aging process and increase the likelihood of comorbidities such as tumors. This is the concept for inflammaging, a term coined by Franceschi et al.[@b1-ccid-11-195],[@b2-ccid-11-195]

Metalloproteinases can aggravate the physiological decrease in the synthesis of collagen and other extracellular matrix elements in the dermis, which is characteristic of chronological aging (intrinsic). The expression of metalloproteinases increases owing to photodamage and inflammatory mechanisms.[@b3-ccid-11-195]

Menopause is also a factor that accelerates degenerative changes in dermal collagen and thickness, resulting in the progressive loss of collagen. The highest loss (of up to 30%) is observed in the first 5 years, followed by a 1%--2% loss of collagen annually. Hormone replacement therapy leads to partial recovery; however, not all patients can undergo this therapy.[@b4-ccid-11-195]

Although oral collagen is widely used in the treatment of skin aging, there is still lack of scientific information about the effects.

Because of the development of technologies that allowed the isolation of peptides for oral intake, this topic is once again being discussed due to the introduction of a new generation of collagen supplements; peptides can increase the expression of certain molecules linked to collagen synthesis; their combination with other substances, such as vitamins and phytoextracts, could enhance this effect.

Similarly, herbal extracts that have antioxidant and anti-inflammatory effects have been studied, with some standing out not only for their effectiveness but also for their safety; their use is an alternative approach in conditions associated with inflammaging.[@b5-ccid-11-195],[@b6-ccid-11-195]

This study was conducted to evaluate the impact of the intake of collagen peptides combined with vitamin C and extracts of *Hibiscus sabdariffa* and *Aristotelia chilensis* (Delphynol®, Anklam Extrakt GmbH, Anklam, Germany) (Eximia Firmalize Age complex®, Farmoquímica S.A., Rio de Janeiro, Brazil) on dermal thickness and to evaluate the consequent improvement in the signs of aging.

Methods
=======

Study design overview
---------------------

The approval to conduct this study was obtained from São Francisco University Ethics Committee prior to the study, which was conducted following Good Clinical Practices.[@b7-ccid-11-195]

Females who complained about and had clinical signs of aging were invited to this open, blinded, and noncomparative study, from November 2016 to February 2017.

Population
----------

Thirty-five females who complained about some degree of skin aging and facial sagging skin were involved. They were included after signing an informed consent form. These patients were aged between 35 and 65 years and did not undergo any dermatological treatment until 4 weeks before the study. Patients using corticosteroids and immunosuppressants and having active endocrinopathies or any medical condition that could interfere with evaluations were excluded.

Intervention
------------

The patients received an oral nutritional supplement containing collagen peptides, vitamin C, *H. sabdariffa*, and *A. chilensis* (Delphynol) in a sachet and were instructed to consume one sachet diluted in 200 mL of water once a day for 12 weeks.

Outcomes
--------

The primary outcome, ie, improvement in skin mechanical properties and dermal thickness, was measured by cutometry and ultrasound on the submental and malar regions (right or left), respectively. Measurements were performed at the beginning of the study and then every month for up to 12 weeks until the end of the study.

The secondary outcome was improvement in skin based on a subjective evaluation.

Procedures
----------

The patients were evaluated for the presence of adverse reactions and effectiveness of treatment by evaluating parameters such as facial skin firmness, elasticity, and texture through a questionnaire with four scores: 1=worsening, 2=slight improvement, 3=moderate improvement, and 4=significant improvement. On the last visit, the patients also assessed regarding the product characteristics (taste and solubility). The instrumental methods used for the evaluations are as follows:

### Cutometry

This is a noninvasive method to evaluate the skin's mechanical properties; it is based on the degree of skin deformity, which is represented by skin firmness and elasticity. The evaluations were always performed in triplicate by the same investigators using Cutometer® MPA 580 (Courage & Khazaka, Cologne, Germany), and an average measurement was obtained.[@b8-ccid-11-195]

### Ultrasonography

Ultrasound exams were performed using Voluson E equipment (GE Healthcare, Little Chalfont, UK) with a multichannel color Doppler and a transducer of up to 15 MHz, which allows the use of a higher resolution with low penetration.[@b9-ccid-11-195]

The same investigator who evaluated the morphological characteristics and thickness of the dermis performed all evaluations. Evaluations were performed in triplicate, and an average measurement was obtained for subsequent comparisons between different study periods.

Assessment by ultrasonography was performed in previously standardized areas: median submental and right and left malar regions, at the midpoint of an imaginary line in the nasal wing of the prominent zygomatic bone. Cutometry measurements were performed in the right or left malar regions.

Sample size and statistical analysis
------------------------------------

Based on previous studies, we expected the cutometry values of skin firmness to decrease and those of elasticity to increase. The evaluation of the 35 patients was expected to detect a difference of at least 15% in both parameters between the evaluation periods at a 95% CI. The ultrasound values of dermal thickness were expected to increase by 5% at a 95% CI.

To evaluate the normality of data distribution, the Shapiro--Wilk test was used to compare the effect of time, whereas the Wilcoxon test was performed using data medians at a significance level of 95%. Student's *t*-test was also used for analysis of ultrasonography and cutometry data.

Results
=======

Of the 35 patients who were included at the beginning of this study, 31 completed all evaluations. These patients were aged between 35 and 65 years (mean age, 51 years). There were 25 Caucasian and 6 African American females. No severe adverse reactions were related by the patients or observed during the study.

Treatment was discontinued in a third patient who was lost to follow-up. Another patient complained about mild and persistent abdominal pain, which was deemed to be related to the treatment because there was complete pain resolution after treatment. There was no need for providing any concomitant medication.

During cutometry, the parameter firmness showed a mean improvement (reduction in measurements) of 10.28% compared with measurements obtained at the beginning of the study in the first evaluation; however, this improvement was not statistically significant (*p*=0.189). At the 8-week evaluation, the mean improvement was 27.82%, which was statistically significant (*p*=0.002). In the final evaluation, a significant 38.31% improvement was observed (*p*\<0.001) ([Figure 1](#f1-ccid-11-195){ref-type="fig"}).

The parameter elasticity showed a mean improvement (increase in measurements) of 20.86% compared with measurements obtained at the beginning of the study in the first evaluation; this improvement was statistically significant (*p*=0.001). At the 8-week evaluation, the mean improvement was 17.8%, which was also statistically significant (*p*=0.022). In the final evaluation, a significant mean improvement of 39.41% was detected (*p*\<0.001) ([Figure 2](#f2-ccid-11-195){ref-type="fig"}).

In the ultrasound evaluations, measurements performed in the submental area showed a mean improvement of 6.07% compared with measurements obtained at the beginning of the study in the first month; this improvement was statistically significant (*p*=0.007). In the 8-week evaluation, the mean improvement was 11.32%, which was also statistically significant (*p*\<0.001). In the final evaluation, a significant mean improvement of 22.38% was observed (*p*\<0.001) ([Figure 3](#f3-ccid-11-195){ref-type="fig"}).

In the 4-week evaluation, the mean improvement in measurements performed in the malar area was 5.81%, compared with measurements obtained at the beginning of the study in the first month; this improvement was statistically significant (*p*=0.001). In the 8-week evaluation, the mean improvement was 14.69%, which was also statistically significant (*p*\<0.001). In the final 12-week evaluation, a significant mean improvement of 24.97% was obtained (*p*\<0.001) ([Figure 4](#f4-ccid-11-195){ref-type="fig"}).

[Figures 5](#f5-ccid-11-195){ref-type="fig"} and [6](#f6-ccid-11-195){ref-type="fig"} show the improvement in the submental and malar regions with time, respectively.

The subjective evaluation of the overall skin appearance showed that 48.4% and 90.3% of the patients noticed a moderate-to-significant improvement in the skin after 4 and 8 weeks, respectively. Identical results were also noticed after 12 weeks in the final evaluation.

With regard to skin elasticity, 58% of the patients perceived a moderate-to-significant improvement after 4 weeks; this percentage was 83.9% at 8 weeks and 93.5% at the end of the study.

With regard to facial skin firmness, 64.52% and 93.5% of the patients noticed a moderate-to-significant improvement after 4 and 8 weeks of treatment, respectively. Identical results were noticed after 12 weeks in the final evaluation.

The patients were also asked about product solubility and taste. Solubility was evaluated based on the difficulty in dissolving the sachet in 200 mL of water, which 87% of the patients reported as being easy or very easy. Regarding taste, 87% of the patients considered the product to taste good or very good.

Discussion
==========

This study showed that treatment with an oral formulation containing collagen peptides, vitamin C, and extracts of *H. sabdariffa* and *A. chilensis* (Delphynol) led to a significant improvement in the mechanical properties of the skin and in dermal thickness. Furthermore, the patients noticed an improvement in the overall appearance of aged skin, skin elasticity, and skin firmness.

The patients also experienced significant improvement in the overall appearance of the skin over time, particularly with respect to skin firmness and elasticity after 3 months of treatment. With regard to the ease of preparation and ingestion of the product, 87% of the patients reported that this factor contributed to adhering to treatment.

Nishimoto et al[@b10-ccid-11-195] used a Wistar rat model to demonstrate the synthesis of collagen based on the hydroxyproline content. They showed that the administration of collagen peptides in rats had a more significant effect on skin collagen synthesis than the administration of gelatin, the level of which was similar than that of the placebo.

Collagen peptides are very similar to collagen, particularly to type I collagen found in the dermis. Therefore, they have the ability to promote collagen type I synthesis, playing a positive role in improving the signs of aging and even in other disorders that involve tissue repair in the dermis.[@b11-ccid-11-195],[@b12-ccid-11-195]

The collagen peptide evaluated in the present study comprised 18 amino acids found in type I collagen, of which eight are essential amino acids. Glycine, proline, and hydroxyproline are the most abundant amino acids, comprising nearly 50% of the total amino acid composition of the collagen peptide.[@b13-ccid-11-195]

Specific dipeptides generated from the digestion of collagen, such as glycine--glutamate and proline--hydroxyproline, are chemotactic for dermal fibroblasts, signaling the "destruction" of collagen and thereby the activation of fibroblasts.[@b14-ccid-11-195]

Moreover, increased synthesis of hyaluronic acid and glycosaminoglycans leads to the activation of hyaluronan synthase 2.[@b15-ccid-11-195],[@b16-ccid-11-195]

Vitamin C is widely known to stimulate the proliferation of fibroblasts.[@b17-ccid-11-195]

In the 1980s, Pinnel et al[@b18-ccid-11-195] showed that [l]{.smallcaps}-ascorbic acid induced the synthesis of procollagen in cultured dermal fibroblasts.

The plant species *H. sabdariffa*, traditionally used in food because of its taste, exhibits antioxidant, lipolytic, hypoglycemic, and diuretic properties in in vitro models. It can also reduce insulin resistance because of its high content in polyphenols such as phenolic acids and proanthocyanidins.[@b19-ccid-11-195]

However, its broad antioxidant action is due to its combination with other compounds present in the extract. The powerful antioxidant action mechanism of *H. sabdariffa* has been studied in tumors, and its major antioxidant compounds have been isolated: chlorogenic, neochlorogenic, and cryptochlorogenic acid; rutin; and isoquercitin.[@b20-ccid-11-195]

Delphinidin is an anthocyanidin found in some plants such as pomegranate and grape; however, its main source is maqui berry (*Aristotelia sinensis*). This plant is endemic to Chile and is part of the diet of Mapuche Indians and some of their rituals. This is one of the populations with the longest life spans in the world.[@b21-ccid-11-195]

Delphinol is a standardized maqui berry extract that provides a higher concentration of flavonoid delphinidin, ie, at least 25% of delphinidins and 35% of total anthocyanidins.[@b22-ccid-11-195],[@b23-ccid-11-195]

In addition to its powerful antioxidant action, delphinidin acts on important stages of inflammation during aging. Its main mechanisms of action are as follows: It increases the expression of endothelial nitric acid synthase and reduces the expression of endothelin 1, thus improving tissue perfusion.[@b24-ccid-11-195]It inhibits the expression of the cell adhesion molecules ICAM and VCAM, COX-2 when the skin is exposed to ultraviolet radiation, and dermal metalloproteinases.[@b25-ccid-11-195],[@b26-ccid-11-195]

When hibiscus, vitamin C, and collagen peptides are combined as an oral supplement, they showed a positive effect on the human dermis, wherein patients had high tolerance and adhered to the treatment.

Conclusion
==========

We conclude that the daily intake of one sachet of our oral nutritional supplement diluted in water for 3 months significantly improves dermal thickness, skin firmness, and elasticity, with most patients noticing an overall improvement in their skin after 4 weeks of treatment, which contributed to treatment adherence and compliance.

Supplements such as the product evaluated herein, which combine molecules with synergistic activities and promote the neutralization of harmful external stimuli, anti-inflammatory effects, and protein synthesis, are a rational and safe choice for adjuvant treatment for skin aging and chronic inflammation associated with skin aging (inflammaging).
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![Mean percentage of improvement in skin firmness measured by cutometry (n=31).\
**Notes:** Values were measured on days 30, 60, and 90.](ccid-11-195Fig1){#f1-ccid-11-195}

![Mean percentage of improvement in elasticity measured by cutometry (n=31).\
**Notes:** Values were measured on days 30, 60, and 90.](ccid-11-195Fig2){#f2-ccid-11-195}

![Mean dermal thickness in the submental region measured by ultrasound (n=31).\
**Notes:** Values were measured on days 0, 30, 60, and 90.](ccid-11-195Fig3){#f3-ccid-11-195}

![Mean dermal thickness in the malar region measured by ultrasound (n=31).\
**Notes:** Measurement was done by ultrasound on days 0, 30, 60, and 90 of treatment.](ccid-11-195Fig4){#f4-ccid-11-195}

![Ultrasound images of the submental region (patient 1).\
**Notes:** Observe the measures in triplicate in each image.](ccid-11-195Fig5){#f5-ccid-11-195}

![Ultrasound images of the malar region (in detail) in patient 1.\
**Notes:** Measurements were obtained in triplicate.](ccid-11-195Fig6){#f6-ccid-11-195}
